About 90% of individuals with OI harbor heterozygous pathogenic variants in the genes that encode the chains of type I collagen (COL1A1 and COL1A2; Van Dijk & Sillence, 2014). This evidence concerns the gene COL1A1 and osteogenesis imperfecta.